Comparison of Blood Loss in Using vs Not Using Placental Cord Drainage After Spontaneous Vaginal Delivery

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03020355

Enrollment

200

Registered

2017-01-13

Start date

2017-02-28

Completion date

2017-06-30

Last updated

2017-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placental Blood Drainage

Brief summary

Comparison of effectiveness of placental blood drainage after spontaneous vaginal delivery in decreasing the duration, blood loss,and complications of the third stage, against no drainage of placental blood.

Detailed description

The patients will prospectively randomized equally into two groups (100 each in the study and control groups). Group-A (Study group)-Placental blood was drained. Group-B (Control group)-Placental blood was not drained. In all the patients detailed medical and obstetric history will taken. In each patient, the pre-delivery pulse rate, blood pressure, and Hb gm% will noted. Immediately after vaginal delivery, after clamping and cutting the cord-the cord will unclamped and the blood will drained until the flow ceased. In the control group, the clamped cord will not released. Blood lost in the third stage of labour will measured by collecting the blood measuring bag.

Interventions

PROCEDUREPlacental Blood Drainage

Immediately after vaginal delivery, after clamping and cutting the cord-the cord will unclamped and the blood will drained until the flow ceased.

PROCEDUREnot Placental Blood Drainage

In the control group, the clamped cord will not released.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

15 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Singleton pregnancy * Vertex presentation * Gestational age of 37 weeks (or) more * No major medical (or) obstetric complications * Spontaneous vaginal delivery

Exclusion criteria

* Hb\\7 gm/dl * History of APH * Instrumental delivery * Multiple pregnancy * Malpresentations * Large baby (more than 3.5 kg) * Polyhydramnios * Known coagulations disorders * Previous surgeries on the uterus

Design outcomes

Primary

Measure	Time frame
Blood lost	through delivery completion, an average of 30 minutes

Secondary

Measure	Time frame	Description
The duration of the third stage	through the duration of the third stage, an average 45 minutes	The duration of the third stage will calculated using a stop watch.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026